Log in to save to my catalogue

Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disea...

Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disea...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A647189602

Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children

About this item

Full title

Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children

Publisher

MDPI AG

Journal title

Biomolecules, 2020, Vol.10 (7)

Language

English

Formats

Publication information

Publisher

MDPI AG

More information

Scope and Contents

Contents

An altered ceramide composition in patients with inflammatory bowel disease (IBD) has been reported recently. The aim of this study was to evaluate the concentrations of sphingolipids in the serum of treatment-naive children with newly diagnosed IBD and to determine the diagnostic value of the tested lipids in pediatric IBD. The concentrations of s...

Alternative Titles

Full title

Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A647189602

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A647189602

Other Identifiers

ISSN

2218-273X

E-ISSN

2218-273X

DOI

10.3390/bioml0071083

How to access this item